<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:51:33Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/13488" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/13488</identifier><datestamp>2026-09-24T20:26:40Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Mishra, Ram</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Sookram, Christal D.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences (Neurosciences)</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T17:04:11Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T17:04:11Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2013-09-25</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2013-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/8319</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">9449</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">4629682</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/13488</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/16680</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Anti-psychotic drug (APD) administration can induce movement disorders including tardive dyskinesia (TD), characterized by abnormal movements of the oro-facial region and occasionally the trunk and limbs. The most widely accepted model of TD is the APD-induced vacuous chewing movement (VCM). While the mechanism of induction of TD remains unclear, there are two prevailing hypothesis: oxidative stress and dopamine supersensitivity. Currently available APDs antagonize dopamine D2 receptors (D2R) which can result in excessive dopamine accumulation and oxidation which was demonstrated to induce striatal neurodegeneration and increased oxidative stress. The dopamine supersensitivity hypothesis proposes that APD treatment causes an up-regulation of high affinity D2Rs to compensate for D2R antagonism. Curcumin, a derivative of turmeric, has been demonstrated to affect dopamine levels and hold significant anti-apoptotic potential. Thus, the goal of this study was to investigate curcumin’s potential to prevent haloperidol-induced behavioural and biochemical abnormalities. Four groups of rats were treated daily: control; haloperidol (at 2mg/kg intra-peritoneally); curcumin (at 200mg/kg orally in jello) and curcumin plus haloperidol. VCMs, catalepsy and locomotor activity were assessed. Animals were sacrificed and tissues removed for qPCR, immunoblot, receptor binding, and UPLC assessments. At day14 there was a significant increase in VCMs and catalepsy following haloperidol treatment, which was prevented by curcumin treatment. However, curcumin did not alter locomotor activity. Curcumin was demonstrated to increase the expression of the anti-apoptotic molecule BclXL and to increase striatal D2Rs. These investigations support the potential of curcumin in the prevention of TD and provide insight into the complex pathophysiology of this disorder.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (Medical Science)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">TARDIVE DYSKINESIA</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">ANTI-PSYCHOTIC DRUGS</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">VACUOUS CHEWING MOVEMENT</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">CATALEPSY</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">LOCOMOTOR ACTIVITY</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">CURCUMIN</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">BclXL</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Behavior and Behavior Mechanisms</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Neurobiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Pharmacology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medicinal and Pharmaceutical Chemistry</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medicine and Health Sciences</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Musculoskeletal, Neural, and Ocular Physiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Natural Products Chemistry and Pharmacognosy</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Neurosciences</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Pharmaceutical Preparations</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Psychiatric and Mental Health</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Behavior and Behavior Mechanisms</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Anti-Psychotic Drug Induced Tardive Dyskinesia: A Role for the Anti-Apoptotic Molecule Curcumin</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>